In 2008 was created Four Partners, which is appeared as Corporate Investor.
The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Four Partners performs on 38 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2011. The average startup value when the investment from Four Partners is 10-50 millions dollars. The top activity for fund was in 2008. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Four Partners, startups are often financed by Prima Industrie, Kitty Hawk Capital, Fuqua Ventures. The meaningful sponsors for the fund in investment in the same round are Prima Industrie, Ersel Asset Management, 360 Capital Partners. In the next rounds fund is usually obtained by Tullis Health Investors, Prima Industrie, Ersel Asset Management.
Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synageva BioPharma.
Fund Name | Location |
Arcturus Capital | California, Pasadena, United States |
Ascender | - |
Asymmetry Ventures | California, San Francisco, United States |
Cintrifuse Syndicate Fund | - |
Cinven | England, London, United Kingdom |
CMS Medical Venture Investment | - |
Council Ventures | Nashville, Tennessee, United States |
France Angels | France, Ile-de-France, Paris |
Green Bank | Houston, Texas, United States |
Greenoaks Capital | California, San Francisco, United States |
Incofin Investment Management | Antwerp, Antwerpen, Belgium |
Marstar Alternative Investments | - |
Moji Fengyun (Beijing) Software Technology Development Co. | Beijing, Beijing, China |
Rock Oak Capital Partners | Illinois, Machesney Park, United States |
Sunlands Online Education Group | Beijing, Beijing, China |
Synergie Finance | Dorset, Gillingham, United Kingdom |
UB Ventures | Chiyoda, Japan |
Ufida Happiness Capital | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.